Three & Two is Better than One
Explore our special offerings for the complete breast solutions.
KOIOS is the first and only patented, proprietary, clinical decision support (DS)
software using AI and machine learning to help to categorize the lesion.
Clinically proven to improve patient outcomes and streamline workflow.
Senographe Pristina sets a high bar for diagnostic confidence and performance,
leveraging the Senographe™ family’s widely recognized image quality.
Comfort for patients, confidence for technologists and clarity for radiologists.
The automated ultrasound examination of the breast with Invenia ABUS offers
an increase in sensitivity when finding invasive breast cancer in the dense breast
tissue if ABUS is used in addition to mammography.
Look no further than GE HealthCare’s unique offers “Three & Two is Better than One”*
Discover revolutionary patient care in your Breast Department with cutting-edge technologies: LOGIQ™ Ultrasound, Invenia ABUS 2.0 and Senographe Pristina.
At a glance
Senographe Pristina (2D & 3D Mammography)
Engineered for a better patient experience along the entire breast care pathway, expertly designed to enhance your everyday capabilities and make patients feel more comfortable.
[Included in Three is Better than One]
Invenia ABUS 2.0
This state-of-the-art system uses non-ionizing radiation and offers automated volumetric 3D ultrasound scanning of the breast. It is designed to image dense breast tissue on all stages: from screening to monitoring.
[Included in Three & Two is Better than One]
LOGIQ Ultrasound
Provides unparalleled image quality and advanced features. With its intuitive design and innovative technology, you can trust that you are getting the most accurate and detailed images every time.
[Included in Three & Two is Better than One]
Screening
Increased breast cancer detection
Regular mammography screening exams can reduce breast cancer mortality for women between the ages of 50-69 years by up to 35%1,2,3. Adding ABUS to mammography screening can increase sensitivity by 57% when detecting breast cancer for women with dense breasts.
Improved patient experience
SenographePristina™ was built with one objective in mind to ease patient anxiety when they enter the exam room. ABUS examination with the reverse curve transducer and the selectable compression levels reduce the patient pain*.
Faster and automated patient examination
By separating the acquisition and the interpretation of the ABUS volume, the radiologist can read the entire exam in 3 minutes.
Diagnosis
Standardized examination procedure
ABUS allows repeatable examinations in 3D and standardized bilateral evaluations. AI on LOGIQ Ultrasound systems with semi-automated segmentation and measure assistant reduces the variability of lesions categorization.
Improved accuracy with excellent image quality
cSound Image former focusing from near field to far field enables a clear depiction and analysis of the smallest tissues abnormalities. Microvascular Imaging (MVI) High-definition flow mode and 2D Shear Wave Elastography will help you with non-invasive assessment of lesion with confident measurements.
Staging
Assist in Surgical Treatment Planning
ABUS provides a full view of the breast depicting the extent of the lesion for a better surgical approach.
SonoBrightHD (CESM) offers high sensitivity imaging helping detect even the smallest lesions within the breasts.
2D Shear Wave Elastography on LOGIQ’s enables non-invasive assessment of lesion stiffness in breast.
Follow-up
Improved follow-up precision
Invenia™ ABUS 2.0 speeds up the workflow and helps with easy side-by-side comparison.
Contrast-Enhanced Ultrasound provides clear picture of tissue structure when there is a need for additional diagnosis.
The new Pristina image chain also helps reduce the exposure time in 2D with no compromise on image quality at low dose. Measurements taken on two Senographe Pristina systems consistently showed close to 30% exposure time reduction.
Non-invasive patient comfort
ABUS provides safe, non-radiation examination and reduces the cost of examination.
Adapt your space for increased cancer detection
Achieve remarkable results using our breast imaging solutions
Breast Imaging
Exceeding your expectations
Exceptional breast systems with AI assistance
Request your quote today and experience improved accuracy and cancer detection rate with top-of-the-line systems.
References
*ABUS disclaimer - Shah et.al.JournalofDiagnosticMedicalSonographyDOI: 10.1177/8756479313476920 2013
- Tabar L, Vitak B, Chen HH, Duffy SW, Yen MF, Chiang CF, Krusemo UB, Tot T, Smith RA. The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am. 2000;38:625–651.
- Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002;359:909–919.
- Bjurstam N, Bjorneld L, Warwick J, Sala E, Duffy SW, Nystrom L, Walker N, Cahlin E, Eriksson O, Hafstrom LO, Lingaas H, Mattsson J, Persson S, Rudenstam CM, Salander H, Save-Soderbergh J, Wahlin T. The Gothenburg Breast Screening Trial. Cancer. 2003;97:2387–2396.
*The availability of offer versions varies by country. The "Two is Better than One" version is available in Croatia, Bulgaria, the Czech Republic, Slovakia, and Slovenia. The "Three is Better than One" version is available in Poland, Greece, Romania, Hungary, Serbia, Bosnia and Herzegovina, Kosovo, and Cyprus. For more information, please contact our Sales Representatives.